NVision has developed a platform which polarizes natural metabolites, enabling these safe molecules to be used as an agent for imaging tumor metabolism via MRI. The company's technology uses quantum physics advances to disrupt the medical imaging and diagnostics space by allowing standard Magnetic Resonance Spectrometers to assess human metabolism, allowing healthcare professionals to perform advanced cancer diagnosis and real-time monitoring of response to therapy.